These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. Rossi B; Sukalich S; Droz J; Griffin A; Cook S; Blumkin A; Guzick DS; Hoeger KM J Clin Endocrinol Metab; 2008 Dec; 93(12):4780-6. PubMed ID: 18812482 [TBL] [Abstract][Full Text] [Related]
43. Ten years cardiovascular risk estimation according to Framingham score and non HDL-cholesterol in blood donors. Graffigna MN; Berg G; Migliano M; Salgado P; Soutelo J; Musso C Diabetes Metab Syndr; 2015; 9(1):24-7. PubMed ID: 25470632 [TBL] [Abstract][Full Text] [Related]
44. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria. Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522 [TBL] [Abstract][Full Text] [Related]
45. Relationship between TG/HDL-C ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population. Ho CI; Chen JY; Chen SY; Tsai YW; Weng YM; Tsao YC; Li WC Clin Nutr; 2015 Oct; 34(5):874-80. PubMed ID: 25304295 [TBL] [Abstract][Full Text] [Related]
46. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients. Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587 [TBL] [Abstract][Full Text] [Related]
48. Discrimination of health risk by combined body mass index and waist circumference. Ardern CI; Katzmarzyk PT; Janssen I; Ross R Obes Res; 2003 Jan; 11(1):135-42. PubMed ID: 12529496 [TBL] [Abstract][Full Text] [Related]
49. Association between nontraditional risk factors and metabolic syndrome in indigenous Argentinean schoolchildren. Hirschler V; Maccallini G; Molinari C; Urrutia IM; Castano On Behalf Of The San Antonio de Los Cobres Study Group LA Diabetes Technol Ther; 2014 Feb; 16(2):84-90. PubMed ID: 24428355 [TBL] [Abstract][Full Text] [Related]
50. Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose. Liu J; Joshi D; Sempos CT Appl Physiol Nutr Metab; 2009 Apr; 34(2):136-42. PubMed ID: 19370043 [TBL] [Abstract][Full Text] [Related]
51. High prevalence of metabolic syndrome in Iran in comparison with France: what are the components that explain this? Azimi-Nezhad M; Herbeth B; Siest G; Dadé S; Ndiaye NC; Esmaily H; Hosseini SJ; Ghayour-Mobarhan M; Visvikis-Siest S Metab Syndr Relat Disord; 2012 Jun; 10(3):181-8. PubMed ID: 22283632 [TBL] [Abstract][Full Text] [Related]
52. Lower birth weight predicts metabolic syndrome in young adults: the Atherosclerosis Risk in Young Adults (ARYA)-study. Ramadhani MK; Grobbee DE; Bots ML; Castro Cabezas M; Vos LE; Oren A; Uiterwaal CS Atherosclerosis; 2006 Jan; 184(1):21-7. PubMed ID: 16326169 [TBL] [Abstract][Full Text] [Related]
53. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset. Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027 [TBL] [Abstract][Full Text] [Related]
54. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects. Vidal J; Morínigo R; Codoceo VH; Casamitjana R; Pellitero S; Gomis R Int J Obes (Lond); 2005 Jun; 29(6):668-74. PubMed ID: 15753955 [TBL] [Abstract][Full Text] [Related]
55. Do the prevalence and components of metabolic syndrome differ among different ethnic groups? A cross-sectional study among obese Malaysian adolescents. Narayanan P; Meng OL; Mahanim O Metab Syndr Relat Disord; 2011 Oct; 9(5):389-95. PubMed ID: 21718129 [TBL] [Abstract][Full Text] [Related]
56. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539 [TBL] [Abstract][Full Text] [Related]
57. Prevalence and predictors of metabolic syndrome among Congolese pre- and postmenopausal women. Muchanga Sifa MJ; Lepira FB; Longo AL; Sumaili EK; Makulo JR; Mbelambela EP; Tozin R; Ngatu NR; Suganuma N Climacteric; 2014 Aug; 17(4):442-8. PubMed ID: 24156784 [TBL] [Abstract][Full Text] [Related]
58. Inflammation and the metabolic syndrome: clustering and impact on survival in a Swedish community-based cohort of 75 year olds. Nilsson G; Hedberg P; Ohrvik J Metab Syndr Relat Disord; 2013 Apr; 11(2):92-101. PubMed ID: 23308380 [TBL] [Abstract][Full Text] [Related]
59. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence. Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231 [TBL] [Abstract][Full Text] [Related]
60. [Prevalence and characteristics of metabolic syndrome in adults admitted to a health care center for ischemic stroke]. Rosas Muñoz M; Rivas Sanhueza R; Daroch Hormazabal C; Guerrero Wyss M; Cea Leiva F Nutr Hosp; 2021 Apr; 38(2):267-273. PubMed ID: 33586993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]